Life Factor La Jeunifique™ NMN+ 15s/6x15s FOC 1box (Exp: 03/2027)

LifeFactor® La Jeunifique™ NMN+ 15's (Exp: 08/2025)La Jeunifique NMN+™ contains a full effective dose of pharmaceutical-grade NMN (99% purity), clinically proven to boost NAD+ levels in human subjects. The formula is enriched with Belight³™, a patented skin-brightening, dermatologist-tested dark-spot corrector from France. -Uthever™ NMN (300mg) | The clinically proven immediate NAD+ precursor. -Uthever™ NMN is a patented, high-purity (99%), high-stability, and clinically proven form of NMN that can boost NAD+ levels in human subjects.-A clinical trial involving 17 postmenopausal women showed that oral administration of 300mg of NMN daily significantly resulted in a reduction of HbA1c, glycative stress in the skin and increment in HDL cholesterol, adiponectin and DHEA-s levels. -The trial also showed a noticeable improvement in skin condition, including a reduction of spots, fine lines, and freckles, improved skin moisturizing, tautness, less noticeable lines, and whitening. All these positive effects were observed after an oral intake of 300mg of NMN daily.-Belight³™ (300mg) | The Patented Skin Brightening, Dark-Spot Corrector (300mg)-Belight³™ is a patented nutricosmetic that offers TRIPLE-ACTIONS brightening effects. It comprises a synergistic blend of grape monomers of flavanols, licorice extract, vitamin C, and grape viniferin, which have all been dermatologically tested and clinically proven to be effective. Specifically, Belight³™ is designed to correct hyperpigmentation, lighten dark spots, and regulate melanin overproduction for a more even and radiant complexion.-Grape viniferin is a dimer of resveratrol, consisting of two resveratrol units joined together. Research studies have shown that grape viniferin is four times more potent than kojic acid and resveratrol in hindering the activity of tyrosinase, an enzyme that participates in the production of melanin responsible for skin pigmentation. -A 60-day single-blind, open-label consumer study involving 100 participants with skin hyperpigmentation under dermatological control, who were administered 300mg of Belight³™ daily, showed remarkable results:-Even skin tone by 30%-Reduced dark spots in 82% of tested subjects -Decreased tyrosinase activity by 85%-Results seen as early as 10 days of supplementation-Reduced age-related dark sports by 30%-Reduced sun-related dark sports by 40% -82% of subjects noticed a reduction of their dark spots after 60 days - Individuals aged ≥ 35 years old- Premature ageing-Cognitive decline- Hectic lifestyles- Tired & lethargic individuals- Melasma & hyperpigmentations- Ageing spots/ sunspots/ dark spots- Uneven skin tone- Dull skin